Dan McHugh is a Co-Founder & Board Member at Tune Therapeutics, and Lead Investor at Yosemite
In his role as Lead Investor at Yosemite, Dan supports companies developing novel therapeutics, diagnostics, and other enabling technologies with the potential for impact in oncology. Prior to Yosemite, he was a Senior Director at Emerson Collective where he led the organization’s life sciences investment efforts. Before joining Emerson Collective, Dan was a strategy consultant at Bain & Co., working primarily with biopharmaceutical and private equity clients.
He holds a B.S. in Bioengineering and an M.S. in Management Science & Engineering, both from Stanford University.